BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

542248

DECCAN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Deccan Health Care Limited Share Price Update

As of the latest trading session, Deccan Health Care Limited share price is currently at ₹ 18.21, which is up by ₹ 0.08 from its previous closing. Today, the stock has fluctuated between ₹ 17.63 and ₹ 18.39. Over the past year, Deccan Health Care Limited has achieved a return of -30.20 %. In the last month alone, the return has been 1.33 %. Read More...

Deccan Health Care Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    37.10

  • P/E Ratio (TTM)

    35.61

  • Beta

    0.94

  • Book Value / share

    44.79

  • Return on equity

    1.70%

  • EPS (TTM)

    0.51

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.16

info icon alternate text

Deccan Health Care Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 20.43
Operating Expense 20.22
Net Profit 0.16
Net Profit Margin (%) 0.78
Earnings Per Share (EPS) 0.07
EBITDA 0.60
Effective Tax Rate (%) 28.57
Particulars SEP 2024 (Values in Cr)
Revenue 18.82
Operating Expense 18.11
Net Profit 0.54
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 0.26
EBITDA 1.12
Effective Tax Rate (%) 25.00
Particulars JUN 2024 (Values in Cr)
Revenue 15.06
Operating Expense 14.57
Net Profit 0.37
Net Profit Margin (%) 2.45
Earnings Per Share (EPS) 0.18
EBITDA 0.87
Effective Tax Rate (%) 24.48
Particulars MAR 2024 (Values in Cr)
Revenue 15.97
Operating Expense 15.68
Net Profit 0.13
Net Profit Margin (%) 0.81
Earnings Per Share (EPS) 0.06
EBITDA 0.67
Effective Tax Rate (%) 56.66
Particulars DEC 2023 (Values in Cr)
Revenue 15.34
Operating Expense 14.53
Net Profit 0.55
Net Profit Margin (%) 3.58
Earnings Per Share (EPS) 0.31
EBITDA 1.24
Effective Tax Rate (%) 32.92
Particulars MAR 2024 (Values in Cr)
Revenue 59.73
Operating Expense 57.50
Net Profit 1.52
Net Profit Margin (%) 2.54
Earnings Per Share (EPS) 0.82
EBITDA 3.77
Effective Tax Rate (%) 32.14
Particulars MAR 2023 (Values in Cr)
Revenue 45.02
Operating Expense 44.50
Net Profit 0.40
Net Profit Margin (%) 0.88
Earnings Per Share (EPS) 0.24
EBITDA 2.07
Effective Tax Rate (%) 24.52
Particulars MAR 2022 (Values in Cr)
Revenue 33.17
Operating Expense 29.45
Net Profit 0.32
Net Profit Margin (%) 0.96
Earnings Per Share (EPS) 0.21
EBITDA 2.16
Effective Tax Rate (%) 40.74
Particulars MAR 2021 (Values in Cr)
Revenue 33.78
Operating Expense 33.31
Net Profit 0.39
Net Profit Margin (%) 1.15
Earnings Per Share (EPS) 0.25
EBITDA 2.10
Effective Tax Rate (%) 25.00
Particulars MAR 2020 (Values in Cr)
Revenue 42.24
Operating Expense 32.17
Net Profit 10.09
Net Profit Margin (%) 23.88
Earnings Per Share (EPS) 6.42
EBITDA 11.73
Effective Tax Rate (%) 0.39
Particulars MAR 2024 (Values in Cr)
Book Value / Share 46.90
ROE % 1.67
ROCE % 2.52
Total Debt to Total Equity 0.02
EBITDA Margin 6.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 47.86
ROE % 0.39
ROCE % 0.68
Total Debt to Total Equity 0.02
EBITDA Margin 4.40
Particulars MAR 2022 (Values in Cr)
Book Value / Share 48.97
ROE % 3.00
ROCE % 5.60
Total Debt to Total Equity 0.01
EBITDA Margin 17.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.76
ROE % 0.51
ROCE % 0.81
Total Debt to Total Equity 0.01
EBITDA Margin 6.22
Particulars MAR 2024 (Values in Cr)
Book Value / Share 46.96
ROE % 1.70
ROCE % 2.53
Total Debt to Total Equity 0.02
EBITDA Margin 6.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 47.91
ROE % 0.50
ROCE % 0.79
Total Debt to Total Equity 0.02
EBITDA Margin 4.60
Particulars MAR 2022 (Values in Cr)
Book Value / Share 48.97
ROE % 3.00
ROCE % 5.60
Total Debt to Total Equity 0.01
EBITDA Margin 17.64
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.76
ROE % 0.51
ROCE % 0.81
Total Debt to Total Equity 0.02
EBITDA Margin 6.22
Particulars MAR 2020 (Values in Cr)
Book Value / Share 48.51
ROE % 13.85
ROCE % 13.87
Total Debt to Total Equity 0.02
EBITDA Margin 27.77
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.60
Total Assets 108.04
Total Liabilities 108.04
Total Equity 96.91
Share Outstanding 20376180
Price to Book Ratio 0.59
Return on Assets (%) 1.38
Return on Capital (%) 1.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.41
Total Assets 96.78
Total Liabilities 96.78
Total Equity 81.56
Share Outstanding 17043200
Price to Book Ratio 0.57
Return on Assets (%) 0.31
Return on Capital (%) 0.37
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.66
Total Assets 90.62
Total Liabilities 90.62
Total Equity 76.94
Share Outstanding 15713430
Price to Book Ratio 0.73
Return on Assets (%) 0.35
Return on Capital (%) 0.41
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.22
Total Assets 92.26
Total Liabilities 92.26
Total Equity 76.62
Share Outstanding 15713430
Price to Book Ratio 0.60
Return on Assets (%) 0.42
Return on Capital (%) 0.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.22
Total Assets 107.32
Total Liabilities 107.32
Total Equity 97.03
Share Outstanding 20376180
Price to Book Ratio 0.59
Return on Assets (%) 1.41
Return on Capital (%) 1.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.36
Total Assets 96.47
Total Liabilities 96.47
Total Equity 81.65
Share Outstanding 17043200
Price to Book Ratio 0.57
Return on Assets (%) 0.41
Return on Capital (%) 0.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.65
Total Assets 90.62
Total Liabilities 90.62
Total Equity 76.94
Share Outstanding 15713430
Price to Book Ratio 0.73
Return on Assets (%) 0.35
Return on Capital (%) 0.42
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.21
Total Assets 92.26
Total Liabilities 92.26
Total Equity 76.62
Share Outstanding 15713430
Price to Book Ratio 0.60
Return on Assets (%) 0.42
Return on Capital (%) 0.5
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.44
Total Assets 92.98
Total Liabilities 92.98
Total Equity 76.23
Share Outstanding 15713430
Price to Book Ratio 0.57
Return on Assets (%) 10.84
Return on Capital (%) 13.08
Particulars MAR 2024 (Values in Cr)
Net Income 2.21
Cash from Operations -11.69
Cash from Investing -0.29
Cash from Financing 14.04
Net change in Cash 1.19
Free Cash Flow -11.38
Particulars MAR 2023 (Values in Cr)
Net Income 0.43
Cash from Operations -6.54
Cash from Investing 0.27
Cash from Financing 5.26
Net change in Cash -1.23
Free Cash Flow -6.54
Particulars MAR 2022 (Values in Cr)
Net Income 3.94
Cash from Operations -0.32
Cash from Investing -0.04
Cash from Financing 0.06
Net change in Cash -0.55
Free Cash Flow -0.20
Particulars MAR 2021 (Values in Cr)
Net Income 0.51
Cash from Operations 0.35
Cash from Investing -0.07
Cash from Financing -0.37
Net change in Cash -0.22
Free Cash Flow 0.45
Particulars MAR 2024 (Values in Cr)
Net Income 2.24
Cash from Operations -11.62
Cash from Investing -0.29
Cash from Financing 13.64
Net change in Cash 0.86
Free Cash Flow -11.31
Particulars MAR 2023 (Values in Cr)
Net Income 0.53
Cash from Operations -6.37
Cash from Investing 0.26
Cash from Financing 5.05
Net change in Cash -1.27
Free Cash Flow -6.37
Particulars MAR 2022 (Values in Cr)
Net Income 3.94
Cash from Operations -0.32
Cash from Investing -0.04
Cash from Financing 0.06
Net change in Cash -0.55
Free Cash Flow -0.20
Particulars MAR 2021 (Values in Cr)
Net Income 0.51
Cash from Operations 0.35
Cash from Investing -0.08
Cash from Financing -0.37
Net change in Cash -0.23
Free Cash Flow 0.44
Particulars MAR 2020 (Values in Cr)
Net Income 10.13
Cash from Operations 2.68
Cash from Investing -1.94
Cash from Financing -1.77
Net change in Cash -1.03
Free Cash Flow 4.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6962.05 76.41 13.35 100103.60 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 75.38 183.85 4.73 141.28 51.01 / 98.70
SHREE PACETRONIX LTD. 70.00 14.58 1.87 25.20 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.68 0.00 2.57 27.88 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6962.05 83.30 12.22 100103.60 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 32.25 0.00 -17.27 24.09 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5560.50 29.47 6.24 6083.19 3750.00 / 6400.00

Deccan Health Care Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
18.16 0.22 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 18.40
  • 26 Days 19.10
  • 10 Days 18.70
  • 50 Days 20.50
  • 12 Days 18.70
  • 100 Days 22.90
  • 20 Days 18.90
  • 200 Days 25.40
18.07 PIVOT

First Support

17.51

First Resistance

18.69

Second Support

16.89

Second Resistance

19.25

Third Support

16.33

Third Resistance

19.87

RSI

42.70

ADX

17.22

MACD

-0.37

Williams % R

-61.90

Commodity Channel Index (CCI)

-60.13

Date

2025-04-30

Week

43758.00

Same Day

7806.00

Month

25155.00

1 Year

0.95

3 Year

0.90

Over 1 Month

1.33%

down

Over 1 Year

-30.20%

down

Over 3 Months

-37.55%

down

Over 3 Years

-22.35%

down

Over 6 Months

-30.42%

down

Over 5 Years

-7.89%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Deccan Health Care Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
74.86%
Promoter Holdings
19.46%
FII
0.0%
DII
5.67%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Minto Purshotam Gupta 3386467.0 (14.46%) Shareholding of Promoter and Promoter Group
Focal Ventures Private Limited 2270896.0 (9.69%) Public Shareholding
Kolla Umanja Venkata Satya Siva Srihari 1558238.0 (6.65%) Public Shareholding
Venture Gurukool Investment Trust 1329750.0 (5.68%) Public Shareholding
Krishna Ventures 1183500.0 (5.05%) Public Shareholding
Meenakshi Gupta 1172143.0 (5.0%) Shareholding of Promoter and Promoter Group
Kolla Sangeetha 608199.0 (2.6%) Public Shareholding
Nihir Chandrakant Shah 549600.0 (2.35%) Public Shareholding
Vikram Sharad Sheth 542020.0 (2.31%) Public Shareholding
Kaushal Ashwin Gandhi 531000.0 (2.27%) Public Shareholding
Hiral Saurabh Shah 400000.0 (1.71%) Public Shareholding
Prasad Rajnikant Sheth 355200.0 (1.52%) Public Shareholding
Surinder Kaur 300000.0 (1.28%) Public Shareholding
Punit Vikram Sheth 257950.0 (1.1%) Public Shareholding

News

Left Arrow
Right Arrow

Deccan Health Care Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Deccan Health Care Limited Share Price

Deccan Health Care Limited was originally incorporated as a Public Limited Company at Hyderabad, Andhra Pradesh on June 14, 1996. The certificate of Commencement of Business was granted on July 03, 1996. Subsequently, the Company was converted into Private Limited Company on June 12, 2009. Further, the Company was converted into Public Company and name of the Company was changed to 'Deccan Health Care Limited' on August 31, 2017.

The Company is developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. With an operating history of more than two decades, the company is primarily known for premium range of nutraceutical, ayurveda and cosmeceutical products. The Company has identified over 50 consumer wellness goals and over 200 diseases, disorders, disabilities which can be prevented by meeting RDA of micronutrients and it has innovated and developed cost effective products that are unique and differentiated to combat such diseases.

The Company was initially engaged in trading of Pharmaceuticals till 2005. From 2005 till 2010 the company was engaged in third party manufacturing. From 2010 onwards, the Company set up its own Manufacturing Facility at Rudrapur, Uttarakhand. The quality of its products is evidenced by the number of quality certifications that the Company has obtained from various local and international accredition agencies. This facility complies with GMP and WHO GMP for its health / diet supplements and ayurvedic products. The Company has also obtained FSSAI license for its products. The Company is also an ISO 9001:2008 certified for Quality management System for manufacturing and supply of Nutraceutical & Pharmaceutical Products. The R&D capabilities enabled the Company to support growth strategy by developing new products and process which enhance its range of products and services.

Apart from this, the Company mainly develop and market differentiated healthcare products specializing in nutraceutical and
cosmeceutical products, which it commercialize through different revenue channels that takes the products solutions to consumers which includes network of distributors, influencers, direct to consumers and e-commerce channel for our domestic sales.

In November 2018, the Company came with an IPO of 42,12,000 Equity Shares comprising of a Fresh Issue of 20,12,000 Equity Shares and an Offer for Sale of 20,00,000 Equity Shares.

In 2019, the Company launched ZnC, an advanced immunity booster, Super Orange chewable delivers a citrus-y-burst of essential nutrients including Zinc and Vitamin C. It also launched Protein +Delicious Protein with Natural Coffee, a unique blend formulated from the union of Protein, Coffee and 75 Micronutrients selected directly from the best harvests.

The Company launched Royal Tea Tree Body Wash; omega 3 hair oil Sachets, Ubtan Body wash, Nurovit MC Total, Sonehaldi and Orthomega during the FY 2021-22.

Parent organization Indian Private
NSE symbol [-]
Founded 1996
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Deccan Health Care Ltd?

Answer Field

The share price of Deccan Health Care Ltd for NSE is ₹ 0.00 and for BSE is ₹ 18.16.

What is the Market Cap of Deccan Health Care Ltd?

Answer Field

The market cap of Deccan Health Care Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 42.50 Cr. as of now.

What is the 52 Week High and Low of Deccan Health Care Ltd?

Answer Field

The 52 Week High and Low of Deccan Health Care Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 39.10 and ₹ 16.00.

How to Buy Deccan Health Care Ltd share?

Answer Field

You can trade in Deccan Health Care Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Deccan Health Care Ltd?

Answer Field

The 1 year returns on the stock has been -30.20%.

What is the Current Share Price of Deccan Health Care Ltd?

Answer Field

Deccan Health Care Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 18.16 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Deccan Health Care Ltd Share?

Answer Field

The market cap of Deccan Health Care Ltd for NSE ₹ 0.0 & for BSE ₹ 42.50 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Deccan Health Care Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Deccan Health Care Ltd share is 35.61.

What is the PB ratio of Deccan Health Care Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Deccan Health Care Ltd share is 44.79.

How to Buy Deccan Health Care Ltd Share?

Answer Field

You can trade in Deccan Health Care Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Deccan Health Care Ltd Share on Bajaj Broking App?

Answer Field

To buy Deccan Health Care Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Deccan Health Care Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|